Value and Evidence, Field Director

Benefits

Additional Information

Company Overview ImmunityBio, Inc. (NASDAQ: IBRX) is a commercial-stage biotechnology company developing cell and immunotherapy products that are designed to help strengthen each patient's natural immune system, potentially enabling it to outsmart the disease and eliminate cancerous or infected cells. We envision a day when we no longer fear cancer, but can conquer it, thanks to the biological wonder that is the human immune system. Our scientists are working to develop novel therapies that harness that inherent power by amplifying both branches of the immune system, attacking cancerous or infected cells today while building immunological memory for tomorrow. The goal: to reprogram the patient's immune system and treat the host rather than just the disease. Why ImmunityBio? - ImmunityBio is developing cutting-edge technology with the goal to transform the lives of patients with cancer and develop next-generation therapies and vaccines that complement, harness and amplify the immune system to defeat cancers and infectious diseases. - Opportunity to join a publicly traded biopharmaceutical company with headquarters in Southern California. - Work with a collaborative team with the ability to work across different areas of the company. - Ability to join a growing company with professional development opportunities. Position Summary The Value and Evidence, Field Director will be a hybrid role integrating evidence generation/HEOR strategy with scientific and pharmacoeconomic communications for ImmunityBio, Inc. products within the United States (U.S.). This role will be responsible for engaging U.S.-based National and Regional managed care accounts, PBMs, Medicaid/Medicare, Integrated Delivery Networks (IDNs), and Federal institutions (DoD, VA) to support optimal patient access in non-muscle invasive bladder cancer (NMIBC), in support of the Market Access team. The Value and Evidence Field Director will align Health Economics and Outcomes Research (HEOR) strategy and evidence generation with payer needs to help educate formulary decision makers on the unmet medical needs in the disease states of interest to while reducing payer uncertainty. The goal is to strengthen the value proposition of ImmunityBio's products and enable appropriate patient access to innovative medicines. This position combines field-based payer engagements with novel evidence generation, pharmacoeconomic modeling, and cross-functional project leadership responsibilities. Essential Functions Partner with the Vice President, Medical Affairs - Strategy to develop and execute medical market access strategies that establish the clinical rationale, economic value, and scientific positioning of ImmunityBio products. Lead medical affairs and HEOR initiatives that support payer engagement and formulary placement by integrating clinical data, competitive intelligence, and payer insights. Develop value-based frameworks and evidence-based arguments that communicate clinical and economic value to C-suite executives, Medical Directors, Pharmacy Directors, and formulary decision-makers. Present integrated clinical, real-world evidence (RWE), and pharmacoeconomic data to payer stakeholders to inform coverage and reimbursement decisions. Author and co-author clinical and pharmacoeconomic abstracts, posters, and presentations for scientific and payer-focused congresses. Utilize FDAMA 114 (Section 3037) tools and communications appropriately across Commercial, PBM, Federal, and State Government accounts. Ensure all payer-focused medical activities comply with company policy, applicable laws, and industry codes while maintaining scientific integrity and risk-management standards. Partner with Medical Affairs, Market Access, Marketing, Clinical Development, Regulatory, Legal, and Advocacy teams to advance HEOR education and patient access to ImmunityBio treatments. Provide real-time payer landscape intelligence to Medical Affairs and Commercial leadership to inform business strategy, early product development, and lifecycle optimization. Contribute to the development and maintenance of Integrated Evidence Generation Plans for marketed and pipeline products. Build and maintain relationships with national and regional payer stakeholders and key opinion leaders (KOLs). Manage project budgets and timelines to deliver high-quality HEOR data and real-world evidence. Lead or contribute to strategic initiatives and special projects that advance Medical Affairs and organizational objectives. Maintain expertise in healthcare economics, payer analytics, and therapeutic innovation; translate emerging trends into actionable strategies that enhance competitive advantage. Perform ad-hoc and cross-functional duties and/or projects, as assigned, to support business needs and provide developmental opportunities. Education & Experience Advanced degree (Ph.D., Pharm.D., M.D., MPH, or equivalent) in a relevant scientific or health‑related discipline required. 10+ years of progress